Comparison of Acute Generalized Exanthematous Pustulosis with Maculopapular Rash in a Swiss Patient Cohort: A Single-Center Retrospective Study
Dermatology · 2025
DOI: 10.1159/000545324 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Dermatology, 2025. Verfasst von Barbara Meier-Schiesser und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University Hospital Zurich, Zurich, Switzerland, fabienne.froehlich@usz.ch. Hauptthemen laut MEDLINE: Acute Generalized Exanthematous Pustulosis, Anti-Bacterial Agents, Exanthema, Drug Eruptions. Die Arbeit nennt 36 Literaturangaben.
Abstract (Originalsprache)
Introduction
Acute generalized exanthematous pustulosis (AGEP) is a rare cutaneous drug reaction characterized by the sudden appearance of non-follicular sterile pustules on an erythematous background which is accompanied by fever and peripheral blood neutrophilia. While the clinical differentiation between AGEP and common delayed-type drug hypersensitivity reactions, such as maculopapular rash (MPR), is well defined, the pathomechanism, causative drugs, and other possible contributing factors remain poorly studied to date.
Methods
In this retrospective case-control study, we compared clinical data on suggested causative drugs, drug testing, and comorbidities between a group of 52 patients with a confirmed diagnosis of AGEP (both clinically and histologically) and a group of 63 patients with confirmed MPR.
Results
Evaluation of the causative drugs revealed that beta-lactam antibiotics represent the most common culprit drug in both AGEP and MPR, while antimycotics (p = 0.002), glucocorticoids (p = 0.0106) and NSAIDs (p = 0.0064) were significantly more frequent in AGEP. Skin patch tests and in vitro lymphocyte transformation tests (LTTs) showed higher positivity rates in MPR compared to AGEP, with all non-beta-lactam antibiotics tested with LTT leading to negative results in AGEP. A detailed analysis of comorbidities suggested a possible association between diseases of the upper gastrointestinal tract and AGEP.
Conclusions
This study highlights the differences in causative drugs and comorbidities between AGEP and MPR, emphasizing the need for further research to enhance the understanding and management of AGEP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, University Hospital Zurich, Zurich, Switzerland, fabienne.froehlich@usz.ch.
- Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
- Department of Biomedicine and Department of Dermatology, University Hospital Basel, Basel, Switzerland.
Zitieren
APA
Meier-Schiesser, B., Fröhlich, F., Wetzstein, D., Nägeli, M. C., Kündig, T., Contassot, E., & Meier-Schiesser, B. (2025). Comparison of Acute Generalized Exanthematous Pustulosis with Maculopapular Rash in a Swiss Patient Cohort: A Single-Center Retrospective Study. Dermatology. https://doi.org/10.1159/000545324
Vancouver
Meier-Schiesser B, Fröhlich F, Wetzstein D, Nägeli MC, Kündig T, Contassot E, et al. Comparison of Acute Generalized Exanthematous Pustulosis with Maculopapular Rash in a Swiss Patient Cohort: A Single-Center Retrospective Study. Dermatology. 2025. doi:10.1159/000545324
BibTeX
@article{MeierSchiesser2025,
author = {Meier-Schiesser, Barbara and Fröhlich, Fabienne and Wetzstein, Dominik and Nägeli, Mirjam C and Kündig, Thomas and Contassot, Emmanuel and Meier-Schiesser, Barbara},
title = {Comparison of Acute Generalized Exanthematous Pustulosis with Maculopapular Rash in a Swiss Patient Cohort: A Single-Center Retrospective Study},
journal = {Dermatology},
year = {2025},
doi = {10.1159/000545324}
}
EUVIMED